PI3K inhibitors changed the p53-induced response of Saos-2 cells from growth arrest to apoptosis

Biochemical and Biophysical Research Communications

Volumn 308, Issue 1, 2003, Pages 120-125

  Ren, Shuo ^a   Gao, ChongFeng ^a,c   Zhang, Lilin ^a,d   Koike, Katsuro ^b   Tsuchida, Nobuo ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b CANCER INSTITUTE   (Japan)

^c VAN ANDEL RESEARCH INSTITUTE   (United States)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; BLOCKING AGENT; CASPASE 3; CASPASE 9; CYTOCHROME C; DNA; MEK INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN BAX; PROTEIN KINASE B; PROTEIN P53; UNCLASSIFIED DRUG; WORTMANNIN;

APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL GROWTH; CELL LINE; CHROMOSOME TRANSLOCATION; DOWN REGULATION; HUMAN; HUMAN CELL; MITOCHONDRION; MUTATION; ONCOGENE; PRIORITY JOURNAL; PROTEIN DEGRADATION; STRESS; TEMPERATURE;

EID: 0041848239     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01309-3     Document Type: Article

References (31)

1. Oren M. Decision making by p53: life, death and cancer. Cell Death Differ. 10:2003;431-442.
2. Vousden K.H., Lu X. Live or let die: the cell's response to p53. Nat. Rev. Cancer. 2:2002;594-604.
3. Sherr C.J., Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1999;1501-1512.
4. Chan T.A., Hwang P.M., Hermeking H., Kinzler K.W., Vogelstein B. Cooperative effects of genes controlling the G(2)/M checkpoint. Genes Dev. 14:2000;1584-1588.
5. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:1995;293-299.
6. Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., Tokino T., Taniguchi T., Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science. 288:2000;1053-1058.
7. Nakano K., Vousden K.H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell. 7:2001;683-694.
8. Matsuda K., Yoshida K., Taya Y., Nakamura K., Nakamura Y., Arakawa H. p53AIP1 regulates the mitochondrial apoptotic pathway. Nat. Cell Biol. 5:2003;216-223.
9. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
10. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
11. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
12. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 13:1999;2905-2927.
13. Bonni A., Brunet A., West A.E., Datta S.R., Takasu M.A., Greenberg M.E. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science. 286:1999;1358-1362.
14. Brunet A., Datta S.R., Greenberg M.E. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr. Opin. Neurobiol. 11:2001;297-305.
15. Erhardt P., Schremser E.J., Cooper G.M. B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway. Mol. Cell. Biol. 19:1999;5308-5315.
16. Ley R., Balmanno K., Hadfield K., Weston C., Cook S.J. Activation of the ERK-1/2 signalling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only Bim. J. Biol. Chem. 278:2003;18811-18816.
17. Simpson L., Parsons R. PTEN: life as a tumor suppressor. Exp. Cell Res. 264:2001;29-41.
18. Fang L., Li G., Liu G., Lee S.W., Aaronson S.A. p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades. EMBO J. 20:2001;1931-1939.
19. Gao C.F., Ren S., Wang J., Zhang S.L., Jin F., Nakajima T., Ikeda M., Tsuchida N. P130 and its truncated form mediate p53-induced cell cycle arrest in Rb(-/-) Saos2 cells. Oncogene. 21:2002;7569-7579.
20. Yamato K., Yamamoto M., Hirano Y., Tsuchida N. Oncogene. 11:1995;1-6.
21. Gottlieb A.R., Granville D.J. Analyzing mitochondrial changes during apoptosis. Methods. 26:2002;341-347.
22. Gao C.F., Ren S., Zhang L., Nakajima T., Ichinose S., Hara T., Koike K., Tsuchida N. Caspase-dependent cytosolic release of cytochrome c and membrane translocation of Bax in p53-induced apoptosis. Exp. Cell Res. 265:2001;145-151.
23. Sionov R.V., Haupt Y. The cellular response to p53: the decision between life and death. Oncogene. 18:1999;6145-6157.
24. Vousden K.H. p53: death star. Cell. 103:2000;691-694.
25. Tsuruta F., Masuyama N., Gotoh Y. The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria. J. Biol. Chem. 277:2002;14040-14047.
26. del Peso L., Gonzalez-Garcia M., Page C., Herrera R., Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science. 278:1997;687-689.
27. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91:1997;231-241.
28. Cardone M.H., Roy N., Stennicke H.R., Salvesen G.S., Franke T.F., Stanbridge E., Frisch S., Reed J.C. Regulation of cell death protease caspase-9 by phosphorylation. Science. 282:1998;1318-1321.
29. Salvesen G.S., Duckett C.S. IAP proteins: blocking the road to death's door. Nat. Rev. Mol. Cell. Biol. 3:2002;401-410.
30. Kovar H., Jug G., Printz D., Bartl S., Schmid G., Wesierska-Gadek J. Characterization of distinct consecutive phases in non-genotoxic p53-induced apoptosis of Ewing tumor cells and the rate-limiting role of caspase 8. Oncogene. 19:2000;4096-4107.
31. Carson J.P., Behnam M., Sutton J.N., Du C., Wang X., Hunt D.F., Weber M.J., Kulik G. Smac is required for cytochrome c-induced apoptosis in prostate cancer LNCaP cells. Cancer Res. 62:2002;18-23.